Share on LinkedInShare on LinkedIn

ARTICLE · 20 FEBRUARY 2003

The War for the Allopathic Medicament Market in Mexico

MexicoIntellectual Property
Oscar González-Vazquez
Oscar González-Vazquez
Author LinkedIn connections

Who could have imagined the current situation of the allopathic medicament market in Mexico 4 years ago?

Approximately four years ago, a tripartite advertising war in the massive communication media took place between laboratories manufacturing allopathic medicaments, that is, innovative medicaments or patent-protected medicaments, laboratories manufacturing interchangeable generic medicaments (GI’s by their initials in Spanish language), and laboratories manufacturing generic or "similar" (look-alikes) medicaments. In this war, each part enhanced the advantages of their products, emphasizing particularly in their respective costs.

The struggle still persists, and this conflict is being taken to other spheres besides the commercial ambit. For instance, the company "Farmacia de Similares" (Similars Pharmacy), which sells medicaments from the "similar" category, has publicly denounced that the Federal Consumers Representative (PROFECO), the Mexican Institute of Industrial Property

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from